Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (OTC Pink - Current Information:AZNCF)

Delayed Data
As of Aug 29
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Big Pharma's Punishment in Court of Public Opinion
11:39am / TheStreet.com - Paid Partner Content
European Markets Mixed as Volatility Hits 17-Month Low
Aug 24 / TheStreet.com - Paid Partner Content
Big Pharma Has No Rx for Viral Social Media Reactions
9:42am / TheStreet.com - Paid Partner Content
Stocks Extend Decline as Crude Falls to One-Week Low
Aug 24 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win
Aug 26 / Zacks.com - Paid Partner Content
Market News Over Summer Vacation: PFE, AZN, TSLA, LZB
Aug 24 / Zacks.com - Paid Partner Content
Company News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
Stocks Slide as Crude Oil Extends Losses
Aug 24 / TheStreet.com - Paid Partner Content
Crude Oil, Health Care Team Up to Pull Wall Street Lower
Aug 24 / TheStreet.com - Paid Partner Content
Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business
Aug 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close64.49
Today’s openn.a.
Day’s range-- - --
Average volume (3 months)849
Market cap$81.6B
Dividend yield4.26%
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)+127.55%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-5.32%
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London


Search for Jobs